ArchiveOSI Brushes Off Hostile Bid, Cancer Stocks SurgePosted by Owen Vater at 12:48PM on March 1st
OSI Pharmaceuticals (OSIP) soared by over 50% on Monday after receiving an unsolicited buyout bid from Astellas Pharma (OTC: ALPMY) worth $52 per share. According to a press release this morning, OSI Pharmaceuticals isn’t interested in the $52 per share offer it received… Healthcare Guru Adds Selected Biotech, Pharma StakesPosted by Max Magee at 10:03AM on November 11th
For healthcare investors, Sectoral Asset Management has been a Pro to watch. According to the firm’s website, it is “an industry-leading specialist in managing global investment portfolios in the healthcare sector” and manages $4 billion in assets. Sectoral has been known… Galleon Scandal Leads to Its DemisePosted by Owen Vater at 10:56AM on October 21st
After surviving the recession, Galleon funds are poised to meet their demise. According to today’s report by The Wall Street Journal, a recent insider trading scandal has led Galleon Group to wind down all of its hedge funds. The company’s founder,… |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |